Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Journal Abstract

Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.

Publication Date: 2024 Aug 20

Full Text Sources

Authors

Yunwen Xu; Shoshana H Ballew; Alexander R Chang; Lesley A Inker; Morgan E Grams; Jung-Im Shin

Abstract

OBJECTIVE

Patients with atrial fibrillation and severe chronic kidney disease have higher risks of bleeding, thromboembolism, and mortality. However, optimal anticoagulant choice in these high-risk patients remains unclear.

Source

Journal of the American Heart Association

Pub Types(s)

Journal Article

Language

English

PubMed ID

39119973